I reported previously (28th May) on Israeli biotech BiomX which develops treatments using human bacteria (microbiome). BiomX has now acquired Israel’s RondinX, which has built a cutting-edge technology platform set to unlock the potential of microbiome therapeutics.
http://www.globes.co.il/en/article-biomx-buys-rondinx-in-israeli-microbiome-merger-1001216994